Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.24 USD | -0.65% | +3.67% | -10.67% |
May. 28 | Bausch + Lomb's New Intraocular Lens Approved by Health Canada | MT |
May. 28 | Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.67% | 5.39B | |
-8.49% | 177B | |
-1.08% | 108B | |
-7.69% | 65.55B | |
+2.81% | 50.66B | |
+6.66% | 42.58B | |
+4.26% | 40.74B | |
+18.48% | 31.07B | |
+10.84% | 25.45B | |
-5.39% | 23.93B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb Brief: Bausch + Lomb and Modulight Announcing FDA Approval of ML6710i Photodynamic Laser for Use with BLCO's VISUDYNE (Verteporfin for Injection)